Anita

Anita Grigoriadis

Jelmar

Jelmar Quist

tom

Tom Hardiman

Radhika

Radhika Kataria

orsi

Orsolya Sipos

Yue

Yue Chen

Fangfang Liu

Chang Liu


Dr Anita Grigoriadis

Senior lecturer in Cancer Bioinformatics

ln

anita

Anita Grigoriadis is a Senior Lecturer in the School of Cancer and Pharmaceutical Sciences at King’s College London (KCL), the School Lead (International) and Training Lead for the CRUK KHP Centre, and holds a guest lecturership at Birkbeck College, University of London. Anita is the lead of “CAncer microBiome ImmuNology DAtascience” (CABINDA), a newly formed initiative between the School of Cancer and Pharmaceutical Sciences, Dental Institute and Faculty of Natural & Mathematical Sciences.

After her Master’s degree at the Institute of Molecular Pathology, University of Vienna (Austria), she pursued a joint PhD between the Ludwig Institute for Cancer Research (LICR), London, and Faculty of Natural Sciences, Salzburg (Austria). Anita conducted her postdoctoral training on breast cancer genomics at the LICR, and later moved to the Breakthrough Breast Cancer Centre (London) with Professor Alan Ashworth. In 2008, she joined the Breast Cancer NOW Unit (formerly Breakthrough Breast Cancer Research) at KCL under the leadership of Professor Andrew Tutt, where her bioinformatics interest in studying genomic instability and immune-related features in breast cancer started.


Dr Jelmar Quist

Postdoctoral Cancer Bioinformatician

ln

Jelmar

Jelmar received his undergraduate degree in Bioinformatics from the University of Applied Sciences Leiden in The Netherlands. After finishing his Master of Research in Bioinformatics with Systems Biology at Birkbeck, University of London, he obtained a PhD studentship in Translational Medicine from the NIHR Biomedical Research Centre at Guy’s and St Thomas’. In 2018, he finished his PhD in Cancer Bioinformatics, focusing on the identification of drivers and dependencies of genomic instability in TNBC. In his current work, he seeks to understand how ectopic expression of HORMAD1 influences the tumour immune microenvironment and DNA damage response sin TNBC, with the aim of optimising patient stratification.

 


Tom Hardiman

PhD Student

ln  GitHub-Mark

Tom

Tom is an MRC-funded PhD student who started in October 2017. His project focuses on understanding the evolution of the premetastatic lymph node niche. He has completed his undergraduate degree in Biochemistry at King’s College London, followed by a Master of Science in Bioinformatics and Theoretical Systems Biology at Imperial College London.

 


Radhika Kataria

PhD Student

Radhika

Radhika is a second year iCASE MRC-DTP PhD student at King’s in collaboration with her industry partner Cambridge Cancer Genomics (CCG). Her project focuses on investigating the presence of the microbiota at the tumour site and their downstream effects in genomic instability and immune infiltration. Prior to her PhD Radhika completed an integrated masters’ degree in Biology specialising in genetics at the University of York.


Dr Orsolya Sipos

Postdoctoral Cancer Bioinformatician

orsi

Orsolya completed her doctoral studies in the Cell Biophysics research group at the Biological Research Centre of the Hungarian Academy of Sciences. After receiving her PhD she worked for the Anthony Nolan Trust, a charity supporting stem cell transplant research, then she joined the Clinical Trials and Statistics Unit of The Institute of Cancer Research (ICR). In September 2017 Orsolya moved to the Bioinformatics Team in the Breast Cancer Now Centre at ICR in collaboration with our group. She is currently working on the data analysis of the Triple Negative breast cancer Trial (TNT) focusing on potential molecular biomarkers. Her main research interests are analysis of integrated multi-omics datasets and applications of machine learning technology in clinical trials.

 


Yue Chen

Student

yue

Yue Chen received his undergraduate in Biomedical Sciences at the University College London. After completing a MRes in translational Oncology at the University of Sheffield, he worked in Next-Generation-Sequencing based clinical diagnostic company in Guangzhou China. Yue’s research focuses on the immune responses of HORMAD1 expressing tumours by integrating the correlation between genomic instability, tissue stress ligands and tumour immune cell infiltration. Yue likes many kinds of sports such as basketball, badminton and swimming.


Dr Fangfang Liu

Postdoctoral Breast Cancer Pathologist

Fangfang Liu received her bachelor’s degree in Clinical Medicine from Tianjin Medical University, followed by a 5 year PhD of Research in Pathology & Oncology at Tianjin Medical University Institute & Cancer Hospital (TCIH),  China. In 2011, after receiving her PhD she started to work as a pathologist in Department of Breast Cancer Pathology in TCIH, focusing on the TILs on prognosis by taking advantage of histological positioning analysis of breast cancer. In 2019 she obtained a scholarship from K.C. Wang Education Foundation and joined the cancer bioinformatics group, aiming to discover the histological and morphological patterns in lymph nodes that are reflective of local and systemic immune responses of breast cancer.


Dr Chang Liu

Postdoctoral Cancer Bioinformatician

Chang joined the cancer bioinformatics group as a bioinformation in January 2019. He finished his BSc in Biological Technology from Nankai University, China in 2012. After that he received his MSc and PhD degree in Bioinformatic from King’s College London, UK in 2014 and 2019, focusing on sequence searching and processing algorithms, especially in weighted sequences and uncertain sequences. In his current work, he aims to apply sequence algorithms to analysis on sequence pattern associated with genomic instability in triple negative breast cancer.